SirReal2 10 mg | 98.96%
TargetMol
SirReal2 is a potent and selective Sirt2 inhibitor with IC50 of 140 nM.
More Information Supplier PageSirReal2
Search Results
SirReal2 100 mg | 98.96%
TargetMol
SirReal2 is a potent and selective Sirt2 inhibitor with IC50 of 140 nM.
More Information Supplier PageSirReal2
PX-478 5 mg | Purity Not Available
TargetMol
PX-478 2HCl is an orally active, and selective inhibitor of hypoxia-inducible factor-1α (HIF-1α).
More Information Supplier PagePX-478
PX-478 10 mg | Purity Not Available
TargetMol
PX-478 2HCl is an orally active, and selective inhibitor of hypoxia-inducible factor-1α (HIF-1α).
More Information Supplier PagePX-478
PX-478 100 mg | Purity Not Available
TargetMol
PX-478 2HCl is an orally active, and selective inhibitor of hypoxia-inducible factor-1α (HIF-1α).
More Information Supplier PagePX-478
P005091 50 mg | Purity Not Available
TargetMol
P005091 is a selective and potent inhibitor of ubiquitin-specific protease 7 (USP7) with EC50 of 4.2 μM.
More Information Supplier PageP005091
SB-705498 5 mg | 98.00%
TargetMol
SB705498 is a TRPV1 antagonist for hTRPV1. SB-705498 has been investigated for the treatment of Rhinitis, Chronic Cough, and Non-allergic Rhinitis.
More Information Supplier PageSB-705498
Sirtinol 10 mg | 99.75%
TargetMol
Sirtinol
Sirtinol 5 mg | 99.75%
TargetMol
Sirtinol
Sofosbuvir 5 mg | 99.93%
TargetMol
Sofosbuvir is a uridine monophosphate analog inhibitor of hepatitis C virus (HCV) polymerase NS5B that is used as an antiviral agent in the treatment of chronic hepatitis C.
More Information Supplier PageSofosbuvir
